Alan Bienstock, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1811900426
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 5th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 82 | $168,350 |
| Cefdinir | 30 | $704 |
| Nystatin | 18 | $343 |
| Doxycycline Hyclate | 45 | $321 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in New York
- Babak MehraraNew York$756K
- Lawrence BassNew York$341K
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Graham SchwarzNew York$125K
- Steven LevineNew York$108K
- Mark AlbertNew York$105K
- Theodore DiktabanNew York$83K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.